Prognostic significance of p53 overexpression in gastric and colorectal carcinoma

作者: T Starzynska , M Bromley , A Ghosh , PL Stern

DOI: 10.1038/BJC.1992.314

关键词:

摘要: p53 expression was examined in 55 gastric and 107 colorectal carcinomas with an immunoperoxidase technique, using the polyclonal antibody CM1 on routinely fixed, paraffin embedded tissue. protein detected 47% 46% found to correlate stage of disease unfavourable clinical outcome (P less than 0.001). Thus, proportion positively reacting neoplasms increased as progressed, tumours which had invaded regional lymph-nodes overexpressed more frequently localised elevated level associated early relapse death. In carcinoma positivity also linked site macroscopic configuration primary tumour most expressed from rectum ulcerative tumours. overexpression irrespective grade. Uniform negative reactivity anti-p53 seen normal epithelium adjacent carcinoma, intestinal metaplasia, atrophic gastritis colonic adenomas. There a good correlation between immunohistochemical staining frozen sections. These studies suggest that detection fixed tissue can be used along other established parameters assess prognostic outcome, especially identify patients poor short-term prognosis.

参考文章(25)
Lane Dp, Iggo R, Bartek J, Gannon J, Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene. ,vol. 5, pp. 893- 899 ,(1990)
William B. Isaacs, Bob S. Carter, Charles M. Ewing, Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Research. ,vol. 51, pp. 4716- 4720 ,(1991)
N Arai, D Nomura, K Yokota, D Wolf, E Brill, O Shohat, V Rotter, Immunologically distinct p53 molecules generated by alternative splicing. Molecular and Cellular Biology. ,vol. 6, pp. 3232- 3239 ,(1986) , 10.1128/MCB.6.9.3232
A. Berchuck, D. L. Clarke-Pearson, Billie-Jo M. Kerns, Andrew M. Davidoff, Robert C. Bast Jr., Jeffrey R. Marks, Jeffrey C. Pence, R. K. Dodge, James Dirk Iglehart, P. A. Humphrey, Overexpression and Mutation of p53 in Epithelial Ovarian Cancer Cancer Research. ,vol. 51, pp. 2979- 2984 ,(1991)
C A Finlay, P W Hinds, T H Tan, D Eliyahu, M Oren, A J Levine, Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Molecular and Cellular Biology. ,vol. 8, pp. 531- 539 ,(1988) , 10.1128/MCB.8.2.531
Setsuo Hirohashi, Masaaki Terada, Takashi Sugimura, Toshimasa Kihana, Gen Tamura, Kazuhiro Nomura, Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Research. ,vol. 51, pp. 3056- 3058 ,(1991)
Jir̂ina Bártkov, Jir̂í Bártek, Jir̂ina Lukáŝ, Bor̂ivoj Vojtêŝek, Zdenka Staŝková, Aleŝ Rejthar, Jan Kovar̂ík, Carol A Midgley, David P Lane, None, p53 Protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia International Journal of Cancer. ,vol. 49, pp. 196- 202 ,(1991) , 10.1002/IJC.2910490209
T Takahashi, M. Nau, I Chiba, M. Birrer, R. Rosenberg, M Vinocour, M Levitt, H Pass, A. Gazdar, J. Minna, p53: a frequent target for genetic abnormalities in lung cancer Science. ,vol. 246, pp. 491- 494 ,(1989) , 10.1126/SCIENCE.2554494
Jiří Bártek, Jiřina Bártková, Bořivoj Vojtěšek, Zdenka Stašková, Aleš Rejthar, Jan Kovařík, David P Lane, None, Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. International Journal of Cancer. ,vol. 46, pp. 839- 844 ,(1990) , 10.1002/IJC.2910460515